Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Recruiting · NCT07251413 · Registry updated 2025-12-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma | Cutaneous Basal Cell Carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-12-01 | NCT07251413 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Instituto Oncológico Dr Rosell | 1 |
| Regeneron Pharmaceuticals | 238 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clínic de Barcelona. Carrer de Villarroel, 170, L'Eixample | Barcelona | Spain | 1 |
| Hospital Miguel Servet de Zaragoza. P.º de Isabel la Católica, 1-3 | Zaragoza | Spain | 1 |
| Hospital Ramón y Cajal. M-607, Km. 9, 100, Fuencarral-El Pardo, | Madrid | Spain | 1 |
| Hospital Universitario Dexeus - Grupo Quirónsalud. Carrer de Sabino Arana, 19 Ed, Distrito de Les Corts | Barcelona | Spain | 1 |